1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 30 NOVEMBER 2015

CNS Drug News 30 NOVEMBER 2015

  • December 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Narcan's Delivery Provides Distinct Advantage
Industry Brief - Impax' Numient Gains EU Approval For PD
Industry Brief - Consilient Health Launches Rasagiline
Industry Trend Analysis - Dementia Research Will See Large Increases In Investment
Industry Trend Analysis - Japanese Copaxone Sales Will Not Forestall US Generic Losses
Industry Brief - Turing Signs Research Agreement With University Of Toledo For Canavan Disease
Industry Brief - Lexapro Approved For Social Anxiety Disorder In Japan
Industry Brief - Mylan Launches Generic Adderall
Industry Brief - Mylan Launches Clozapine
Industry Trend Analysis - Depomed Bolsters Defences Against Horizon Hostile Takeover
Industry Brief - Mylan Launches Almotripan In US
Industry Trend Analysis - Ionsys Will Provide Significant Competitive Edge For The Medicines Company
Industry Brief - Teva/Heptares Sign Licensing Deal To Develop CGRP Antagonists For Migraine
Industry Brief - CHMP Recommends UCB's Brivaracetam For Epilepsy
Industry Brief - E Keppra Injectable To Be Launched In Japan
Industry Trend Analysis - Extended Release Belviq Will Not Renew Blockbuster Hopes
Industry Brief - Tesaro's Varubi Available In US
Industry Brief - Lee's Gains Rights To Solasia's Sancuso In China
Industry Trend Analysis - Rare CNS Disorders Represent Key Diversification Targets
Industry Trend Analysis - Heptares Collaboration Opens Up New Targets For Pfizer
Industry Brief - Newron Raises Funds To Develop Sarizotan For Rett Syndrome
Industry Trend Analysis - Early Adoption Of Open Innovation To Set Companies Apart

Table Of Contents

CNS Drug News 30 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...

Epiomic Epidemiology Series: Bell%s Palsy Forecast in 15 Major Markets 2017-2027

Epiomic Epidemiology Series: Bell%s Palsy Forecast in 15 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • February 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Bell’s palsy in 15 Major Markets Bell's palsy, also known as idiopathic facial nerve palsy, is a weakness of the muscles on one side ...

Epiomic Epidemiology Series: Muscular Dystrophies Forecast in 12 Major Markets 2017-2027

Epiomic Epidemiology Series: Muscular Dystrophies Forecast in 12 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • January 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Muscular Dystrophies in 12 Major Markets The muscular dystrophies (MD) are a group of more than 30 genetic diseases characterized by ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.